Results 181 to 190 of about 4,134,598 (285)
Single‐cell multi‐omics reveals epigenetic heterogeneity across therapy‐adaptive tumor states, including quiescent/dormant, drug‐tolerant persister, and EMT‐like phenotypes. By linking regulatory features with state‐associated biomarkers, these approaches inform biomarker‐guided therapeutic strategies for evolving tumors.
Hee Jung Kim +3 more
wiley +1 more source
To the Editor: Reply to "Clinical Decision Rules: A Starting Place in Medical Education, Not a Destination". [PDF]
Baggett N.
europepmc +1 more source
Deciphering human decision rules in motion discrimination. [PDF]
Huang J, Yu A, Zhou Y, Liu Z.
europepmc +1 more source
Breast cancer remains a major cause of cancer death in women, frequently developing endocrine therapy resistance. This study demonstrates that upregulated p21‐activated kinase 1 (PAK1) activity drives resistance to tamoxifen and long‐term estrogen deprivation in ER+ breast cancer models.
Luisa Schwarzmüller +10 more
wiley +1 more source
A New Paradigm for Generative Adversarial Networks based on Randomized Decision Rules. [PDF]
Kim S, Song Q, Liang F.
europepmc +1 more source
Matched spatial transcriptomics and single‐nuclei RNA‐seq were generated for anaplastic and BRAFV600E papillary thyroid cancers revealing generic and tumor‐specific states occurring in cancer cells and in the tumor microenvironment. In this context, cancer dedifferentiation mirrored organoid maturation through ordered thyroid marker gain/loss ...
Adrien Tourneur +11 more
wiley +1 more source
Decision Rules in Frequentist and Bayesian Hypothesis Testing: P-Value and Bayes Factor. [PDF]
Fordellone M +4 more
europepmc +1 more source
Self-matched learning to construct treatment decision rules from electronic health records. [PDF]
Xu T, Chen Y, Zeng D, Wang Y.
europepmc +1 more source

